MARC details
| 000 -LEADER |
| fixed length control field |
03064ntm a2200349 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
MY-KuUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20260302162631.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
t||||fs|||| 000 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
c| |||aaa||||a |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
260302t20252025my a|||fs|||| 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
THE0010409 (Local) |
| Qualifying information |
Hardback |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
UMPSA |
| Language of cataloging |
eng |
| Transcribing agency |
UMPSA |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FIST .H86 2025 r Bc. |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Mathumittha Tamil Selvan, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
| Title |
The formulation and effect of tiger milk mushroom and cordyceps from hot water extraction method for therapeutic applications / |
| Statement of responsibility, etc. |
Mathumittha Tamil Selvan |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMPSA, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2025 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Date of production, publication, distribution, manufacture, or copyright notice |
© 2025 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xiii, 70 pages : |
| Other physical details |
illustrations ; |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
| Source |
rda |
| File type |
text file |
| Encoding format |
PDF |
| 500 ## - GENERAL NOTE |
| General note |
Faculty of Industrial Sciences and Technology |
| 502 ## - DISSERTATION NOTE |
| Dissertation note |
Final Year Report (Bachelor of Applied Science in Industrial Biotechnology) -- Universiti Malaysia Pahang Al-Sultan Abdullah - 2025 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
Include bibliographical reference |
| 520 3# - SUMMARY, ETC. |
| Summary, etc. |
This study explores the therapeutic potential of tiger milk mushroom (Lignosus rhinocerus) and cordyceps (Cordyceps sinensis) extracts, focusing on their antiinflammatory and antioxidant properties when formulated in different ratios. Using hot water extraction, the study prepared five formulations, including pure extracts of each mushroom and combinations in ratios of 1:1, 1:2, and 2:1. These formulations were evaluated for bioactivity through assays such as Bovine Serum Albumin (BSA) denaturation for anti-inflammatory properties and DPPH radical scavenging and FRAP assays for antioxidant potential. The findings revealed that all formulations displayed significant bioactivity, with the 2:1 ratio of tiger milk mushroom to cordyceps (Formulation 5) demonstrating the highest efficacy in both its anti-inflammatory and antioxidant properties, highlighting a synergistic interaction when compared to the 1:1 and 1:2 ratios. Chemical analysis using FTIR and HPLC confirmed the presence of bioactive compounds, including phenolic acids, and other antioxidant agents, which are key contributors to the observed effects. The study underscores the synergistic potential of these mushrooms in combating oxidative stress and inflammation-related diseases, presenting a natural, low-side-effect alternative to conventional therapies. The study paves the way for the development of safe and effective natural formulations as alternatives to conventional drugs with fewer side effects. Moreover, these results offer a foundation for future research, including in vivo studies and large-scale production, to further explore and optimize these natural formulations for therapeutic use. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
Faculty of Industrial Sciences and Technology |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Universities and colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Final Year Report |
| General subdivision |
Dissertations |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
http://umpir.ump.edu.my/id/eprint/45757 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Thesis |